Stay Updated with the Latest Orion180 Insurance Group, Inc. Class A OIG News in Real Time
Find OIG news now at Meyka AI. Stay informed with the latest Orion180 Insurance Group, Inc. Class A stocks updates, including price news, market analysis, and expert insights.
Who Runs the NDIS? NDIA, Approved Services and Choosing a Provider
Most people come to the NDIS with one simple question: who do I actually talk to? Behind every plan sits a chain of organisations, from Parliament to the therapist who knocks on your door. Each has a different job, and knowing those roles helps you get faster answers, make better choices and spot problems early….
Jacques Moretti Hearing: Crans-Montana Fire Questions Remain
Jacques Moretti faced nine hours of questions on Nov 2. We explain the Crans-Montana fire investigation and what comes next.
Guided Retirement: UK’s New Default Pension Plan Explained
Guided retirement would give 17 million UK workers a default pension that pays for life. See how it works and what changes.
Michael Jackson Estate Trust: Paris Jackson Seeks $600M
Michael Jackson estate trust: Paris Jackson asks a court to move $600M into the family trust. See what both sides say.
Bill Ackman AI Capex Call: Why He Backs the Hyperscalers
Bill Ackman AI capex view: Pershing Square says Big Tech’s $740B spending is offensive, not defensive. Key numbers inside.
Anthropic S-1 Filing Reveals $17B Q3 Revenue and $895B in Compute Deals
Anthropic S-1 filing shows $17B Q3 revenue, a $104B nine-month loss and $895B in compute deals. Here is what it means for investors.
Binance Recovery: 95% Assets Back, Withdrawals Open
Binance recovery update: about 95% of assets are replenished, withdrawals resumed in phases on November 1, and the Proof of Reserves for ten major tokens is now live.
Westpac Profit Slips 1% to $6.8B as RBA Lifts Rates
Westpac profit fell 1% to $6.8 billion in FY26 as costs, bad-loan charges and margins came under pressure. We explain the result, the 250 job cuts and the RBA rate hike to 4.85%.
Roche Share Price Dips After UBS Downgrade to Neutral
UBS cut Roche to Neutral on November 2 but raised its target to CHF 420. We explain why the Roche share price slipped to CHF 397.20, what giredestrant means and what analysts expect next.